BFRI

Biofrontera Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$0.93

Price (1 Year)

$1.61 $0.72

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %55.7 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions.

Website

Analysis (Turkish): BFRI Hissesi Caiz mi, Helal mi? Biofrontera Inc. Katılım Analizi